feed,title,long_url,short_url
Benzinga,* * REVISED TIME * * CytoDyn to Hold Webcast on October 20 to Discuss DSMC's Recommendations from the Interim Analysis of the Phase 2b/3 Clinical Trial for Severe-to-Critical COVID-19 Patients,https://www.benzinga.com/pressreleases/20/10/g17967693/revised-time-cytodyn-to-hold-webcast-on-october-20-to-discuss-dsmcs-recommendations-from-the-inter,https://j.mp/37mcHPT
